Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
26M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
6.58M
-
Shares change
-
-39.3K
-
Total reported value, excl. options
-
$86.7M
-
Value change
-
-$755K
-
Number of buys
-
30
-
Number of sells
-
-26
-
Price
-
$13.18
Significant Holders of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) as of Q1 2025
76 filings reported holding RNAC - Cartesian Therapeutics, Inc. - COMMON STOCK as of Q1 2025.
Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.58M shares
of 26M outstanding shares and own 25.34% of the company stock.
Largest 10 shareholders include FMR LLC (2.34M shares), MPM BIOIMPACT LLC (791K shares), BlackRock, Inc. (673K shares), Siren, L.L.C. (563K shares), VANGUARD GROUP INC (504K shares), Erste Asset Management GmbH (260K shares), GEODE CAPITAL MANAGEMENT, LLC (226K shares), STATE STREET CORP (201K shares), JPMORGAN CHASE & CO (195K shares), and 683 Capital Management, LLC (150K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.